Stephen P. Fortmann, MD

Clinical Focus

• Cardiology (Heart), Preventive
• Internal Medicine
• Primary Prevention

Administrative Appointments

• Director, Stanford Prevention Research Center , (1998– present )

Honors and Awards

• Member, Institute of Medicine of the National Academies (2005)
• Fellow, Society for Behavioral Medicine (1983)
• Fellow, American Heart Association (1984)
• Fellow, American College of Physicians (1987)
• Fellow, American College of Epidemiology (1988)

Professional Education

• SUMC - Graduate Medical Education (1979) CA
• Board Certification: Internal Medicine, American Board of Internal Medicine (1977)
• Santa Clara Valley Medical Center (1977) CA USA
• Santa Clara Valley Medical Center (1975) CA USA
• UCSF School of Medicine (1974) CA
• A.B., Stanford Universtiy Biology (1970)
• M.D., Univ. of Calif., San Francisco Medicine (1974)

Postdoctoral Advisees

• Dipanjan Banerjee, Matthew Buman, Mindy Dopler Nelson, Eric Hekler, Valarie Jernigan, Marina Martin, Susan Moore, Stacy Sims

Graduate & Fellowship Program Affiliations

• Epidemiology
• Medicine

Community & International Work

• MONICA (Multinational MONItoring of trends and determinants in CArdiovascular disease) Project More »

Web Site Links

• Stanford Prevention Research Center

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. 

• Consulting: Access Business Group

Research Interests

ACTIVE STUDIES

1 RO1 DA017441 (PI Killen); 9/30/03–6/30/08; NIH/NIDA
Behavioral Maintenance Treatment for Smoking Cessation
To examine the effectiveness of a multi-factor maintenance treatment strategy in promoting longer-term smoking abstinence.
Role: Co-PI

2 R01 CA67850 (Fortmann); 08/02/05–4/30/10; NIH/NCI
Impact of Retail Tobacco Advertising on Youth Smoking
This project is a longitudinal survey to determine effects of exposure to retail tobacco advertising on smoking initiation.

5 R01 DA017457 (Killen);09/30/03-7/31/09; NIH/NIDA
Selegeline Patch for Treatment of Nicotine Dependence
To conduct the first randomized controlled trial of the efficacy of selegiline patch for the treatment of nicotine dependence.
Role: Co-PI, Medical Director

1 R01 HL87647-01 (PI Quertermous); 09/30/06–07/31/09; NIH
Whole Genome Association for Early Coronary Artery Disease and Related Phenotypes
Among the Atherosclerotic Disease, Vascular Function, and Genetic Epidemiology (ADVANCE) cohorts that enrolled cases of coronary disease and disease-free controls across a broad age spectrum, we propose to conduct a whole genome association study on 1,040 subjects followed by a second stage of focused genotyping on a separate sample of 2,093 subjects, as well as replication of the most significant findings with collaborating external investigators.
Role: Investigator

2 T32 HL07034 Fortmann (PI); 08/1/06 –07/31/11; NIH/NHLBI
Cardiovascular Disease Prevention Training Program
This Training Program is an institutional National Research Service Award with 8 postdoctoral positions; it provides training for behavioral scientists and physicians in interdisciplinary CVD prevention research.

17RT-0152 (Henriksen); 07/01/08-06/30/11;Tobacco-Related Disease Research Program (TRDRP)
Association of Outlet Density with Smoking and Pack Price
This study seeks to understand whether the concentration of stores that sell cigarettes in a neighborhood, and the widespread cigarette advertising these stores contain, create an environment that promotes tobacco use.
Role: Co-PI

U54 RR0234374 (Greenberg); 05/19/08-9/30/13; NIH
The Stanford Center for Clinical and Translational Education and Research (Spectrum)
This is Stanford’s Clinical and Translational Science Award (CTSA) which provides extensive infrastructure support for conducting these types of research.
Role: Community Engagement Program Director

R01DK081371-01 (Palaniappan); 01/15/09-12/31/13; NIH/NIDDK
Identifying Disparities in Type 2 Diabetes Among Asian Americans: The Pan Asian Cohort Study (PACS)
This study will provide a greater understanding of diabetes among Asian ethnic minorities in a comparable environment, and will contribute both to a global understanding of risk for Asian populations and to more targeted research, public health and clinical efforts throughout the U.S. This study is being conducted at the Palo Alto Medical Foundation Research Institute.
Role: Co-PI
http://www.pamf.org/pacs/

RECENTLY COMPLETED STUDIES

PI (Fortmann); 07/30/07-07/29/08; American Cancer Society, Inc.
Colloquium Series to Discuss an International Tobacco Control Program
The Stanford Global Tobacco Free Research Initiative is currently in its early planning phase. During academic year 2007-2008, it will be sponsoring a series of colloquia presented by international tobacco-control experts.

Fortmann (PI); 10/1/00–09/30/06; Donald W. Reynolds Foundation
Genetic Epidemiology of Cardiovascular Disease and Healthy Aging (PI) [Project 3 of the Donald W. Reynolds Cardiovascular Clinical Research Center at Stanford University (M. Hlatky, PI)]
This was a study of CVD epidemiology that includes case-control association studies for genetic polymorphisms in selected candidate genes and cross-sectional and longitudinal studies of novel risk factors and subclinical CVD in a cohort of healthy men and women aged 60-69.

Publications

• Insulin resistance independently predicts the progression of coronary artery calcification. Lee KK,  Fortmann SP, Fair JM, Iribarren C, Rubin GD, Varady A, Go AS, Quertermous T, Hlatky MA.  Am Heart J.  2009; 157 (5): 939-45
• Distribution of Asymmetric Dimethylarginine among 980 Healthy, Older Adults of Different Ethnicities. Sydow K,  Fortmann SP, Fair JM, Varady A, Hlatky MA, Go AS, Iribarren C, Tsao PS.  Clin Chem.  2009;
• Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Assimes TL,  Knowles JW, Basu A, Iribarren C, Southwick A, Tang H, Absher D, Li J, Fair JM, Rubin GD, Sidney S, Fortmann SP, Go AS, Hlatky MA, Myers RM, Risch N, Quertermous T.  Hum Mol Genet.  2008; 17 (15): 2320-8
• Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Assimes TL,  Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, Tabor HK, Hartiala J, Allayee H, Grove ML, Tabibiazar R, Sidney S, Fortmann SP, Go A, Hlatky M, Iribarren C, Boerwinkle E, Myers R, Risch N, Quertermous T.  Hum Genet.  2008; 123 (4): 399-408
• Receptivity to alcohol marketing predicts initiation of alcohol use. Henriksen L,  Feighery EC, Schleicher NC, Fortmann SP.  J Adolesc Health.  2008; 42 (1): 28-35
• Is adolescent smoking related to the density and proximity of tobacco outlets and retail cigarette advertising near schools? Henriksen L,  Feighery EC, Schleicher NC, Cowling DW, Kline RS, Fortmann SP.  Prev Med.  2008; 47 (2): 210-4
• Extended cognitive behavior therapy for cigarette smoking cessation. Killen JD,  Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, Celio M, Cromp D, Fong D, Pandurangi M.  Addiction.  2008; 103 (8): 1381-90
• Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification Terashima M,  Nguyen PK, Rubin GD, Iribarren C, Courtney BK, Go AS, Fortmann SP, McConnell MV.  J. Am. Coll. Cardiol. Img..  2008; 1 167-173
• Incidental pulmonary nodules on cardiac computed tomography: prognosis and use. Iribarren C,  Hlatky MA, Chandra M, Fair JM, Rubin GD, Go AS, Burt JR, Fortmann SP.  Am J Med.  2008; 121 (11): 989-96
• Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification. Terashima M,  Nguyen PK, Rubin GD, Iribarren C, Courtney BK, Go AS, Fortmann SP, McConnell MV.  JACC Cardiovasc Imaging.  2008; 1 (2): 167-73
• Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. Knowles JW,  Assimes TL, Boerwinkle E, Fortmann SP, Go A, Grove ML, Hlatky M, Iribarren C, Li J, Myers R, Risch N, Sidney S, Southwick A, Volcik KA, Quertermous T.  BMC Med Genet.  2008; 9 23
• A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Assimes TL,  Knowles JW, Priest JR, Basu A, Borchert A, Volcik KA, Grove ML, Tabor HK, Southwick A, Tabibiazar R, Sidney S, Boerwinkle E, Go AS, Iribarren C, Hlatky MA, Fortmann SP, Myers RM, Kuhn H, Risch N, Quertermous T.  Atherosclerosis.  2008; 198 (1): 136-44
• Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. Burt JR,  Iribarren C, Fair JM, Norton LC, Mahbouba M, Rubin GD, Hlatky MA, Go AS, Fortmann SP.  Arch Intern Med.  2008; 168 (7): 756-61
• Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Kumanyika SK,  Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP, Franklin BA, Gillman MW, Lewis CE, Poston WC, Stevens J, Hong Y.  Circulation.  2008; 118 (4): 428-64
• The relationship between exposure to alcohol advertising in stores, owning alcohol promotional items, and adolescent alcohol use. Hurtz SQ,  Henriksen L, Wang Y, Feighery EC, Fortmann SP.  Alcohol Alcohol.  2007 Mar-Apr; 42 (2): 143-9
• Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. Taylor-Piliae RE,  Haskell WL, Iribarren C, Norton LC, Mahbouba MH, Fair JM, Hlatky MA, Go AS, Fortmann SP.  J Cardiopulm Rehabil Prev.  2007 Jul-Aug; 27 (4): 227-32
• Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Hlatky MA,  Ashley E, Quertermous T, Boothroyd DB, Ridker P, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS.  Am Heart J.  2007; 154 (6): 1043-51
• Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Knowles JW,  Wang H, Itakura H, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS, Quertermous T, Hlatky MA.  Am Heart J.  2007; 154 (6): 1052-8
• Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Itakura H,  Sobel BE, Boothroyd D, Leung LL, Iribarren C, Go AS, Fortmann SP, Quertermous T, Hlatky MA.  Am Heart J.  2007; 154 (6): 1059-64
• Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years. Fair JM,  Kiazand A, Varady A, Mahbouba M, Norton L, Rubin GD, Iribarren C, Go AS, Hlatky MA, Fortmann SP.  Am J Cardiol.  2007; 100 (6): 981-5
• Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Ardigo D,  Assimes TL, Fortmann SP, Go AS, Hlatky M, Hytopoulos E, Iribarren C, Tsao PS, Tabibiazar R, Quertermous T.  Physiol Genomics.  2007; 31 (3): 402-9
• Plasma leptin levels and coronary artery calcification in older adults. Iribarren C,  Husson G, Go AS, Lo JC, Fair JM, Rubin GD, Hlatky MA, Fortmann SP.  J Clin Endocrinol Metab.  2007; 92 (2): 729-32
• Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Hlatky MA,  Quertermous T, Boothroyd DB, Priest JR, Glassford AJ, Myers RM, Fortmann SP, Iribarren C, Tabor HK, Assimes TL, Tibshirani RJ, Go AS.  Am Heart J.  2007; 154 (6): 1035-42
• Elective and isolated carotid endarterectomy: health disparities in utilization and outcomes, but not readmission. Kennedy BS,  Fortmann SP, Stafford RS.  J Natl Med Assoc.  2007; 99 (5): 480-8
• Extended treatment with bupropion SR for cigarette smoking cessation. Killen JD,  Fortmann SP, Murphy GM, Hayward C, Arredondo C, Cromp D, Celio M, Abe L, Wang Y, Schatzberg AF.  J Consult Clin Psychol.  2006; 74 (2): 286-94
• Sociocultural factors that affect pregnancy outcomes in two dissimilar immigrant groups in the United States. Madan A,  Palaniappan L, Urizar G, Wang Y, Fortmann SP, Gould JB.  J Pediatr.  2006; 148 (3): 341-6
• Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? Iribarren C,  Go AS, Husson G, Sidney S, Fair JM, Quertermous T, Hlatky MA, Fortmann SP.  J Am Coll Cardiol.  2006; 48 (9): 1800-7
• Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Go AS,  Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, Hlatky MA.  Ann Intern Med.  2006; 144 (4): 229-38
• Industry sponsored anti-smoking ads and adolescent reactance: test of a boomerang effect. Henriksen L,  Dauphinee AL, Wang Y, Fortmann SP.  Tob Control.  2006; 15 (1): 13-8
• Validation of a new brief physical activity survey among men and women aged 60-69 years. Taylor-Piliae RE,  Norton LC, Haskell WL, Mahbouda MH, Fair JM, Iribarren C, Hlatky MA, Go AS, Fortmann SP.  Am J Epidemiol.  2006; 164 (6): 598-606
• An evaluation of four measures of adolescents' exposure to cigarette marketing in stores. Feighery EC,  Henriksen L, Wang Y, Schleicher NC, Fortmann SP.  Nicotine Tob Res.  2006; 8 (6): 751-9
• Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Kinder LS,  Carnethon MR, Palaniappan LP, King AC, Fortmann SP.  Psychosom Med.  2004 May-Jun; 66 (3): 316-22
• Reaching youth at the point of sale: cigarette marketing is more prevalent in stores where adolescents shop frequently. Henriksen L,  Feighery EC, Schleicher NC, Haladjian HH, Fortmann SP.  Tob Control.  2004; 13 (3): 315-8
• Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Palaniappan L,  Wang Y, Fortmann SP.  Ann Epidemiol.  2004; 14 (7): 499-506
• Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Palaniappan L,  Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, Haffner SM, Wagenknecht L.  Diabetes Care.  2004; 27 (3): 788-93
• Association of retail tobacco marketing with adolescent smoking. Henriksen L,  Feighery EC, Wang Y, Fortmann SP.  Am J Public Health.  2004; 94 (12): 2081-3
• Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study. Jamison RL,  Hartigan P, Gaziano JM, Fortmann SP, Goldfarb DS, Haroldson JA, Kaufman J, Lavori P, McCully KS, Robinson K.  Clin Trials.  2004; 1 (5): 451-60
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group. Fortmann SP,  Ford E, Criqui MH, Folsom AR, Harris TB, Hong Y, Pearson TA, Siscovick D, Vinicor F, Wilson PF.  Circulation.  2004; 110 (25): e554-9
• Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. Wrone EM,  Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP.  J Am Soc Nephrol.  2004; 15 (2): 420-6
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Pearson TA,  Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F.  Circulation.  2003; 107 (3): 499-511
• Onset of major depression during treatment for nicotine dependence. Killen JD,  Fortmann SP, Schatzberg A, Hayward C, Varady A.  Addict Behav.  2003; 28 (3): 461-70
• Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998. Carnethon MR,  Fortmann SP, Palaniappan L, Duncan BB, Schmidt MI, Chambless LE.  Am J Epidemiol.  2003; 158 (11): 1058-67
• Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. Carnethon MR,  Kinder LS, Fair JM, Stafford RS, Fortmann SP.  Am J Epidemiol.  2003; 158 (5): 416-23
• Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. Wrone EM,  Carnethon MR, Palaniappan L, Fortmann SP.  Am J Kidney Dis.  2003; 41 (3): 580-7
• Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Luepker RV,  Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy KS, Roger VL, Rosamond WD, Shahar E, Sharrett AR, Sorlie P, Tunstall-Pedoe H.  Circulation.  2003; 108 (20): 2543-9
• American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Pearson TA,  Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF, Smith S, Stone NJ, Taubert KA.  Circulation.  2003; 107 (4): 645-51
• Association between microalbuminuria and the metabolic syndrome: NHANES III. Palaniappan L,  Carnethon M, Fortmann SP.  Am J Hypertens.  2003; 16 (11 Pt 1): 952-8
• AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Pearson TA,  Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF, Smith SC, Stone NJ, Taubert KA.  Circulation.  2002; 106 (3): 388-91
• Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. Palaniappan LP,  Carnethon MR, Fortmann SP.  Diabetes Care.  2002; 25 (8): 1351-7
• Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987-1998. Carnethon MR,  Palaniappan LP, Burchfiel CM, Brancati FL, Fortmann SP.  Diabetes Care.  2002; 25 (8): 1358-64
• Do men outperform women in smoking cessation trials? Maybe, but not by much. Killen JD,  Fortmann SP, Varady A, Kraemer HC.  Exp Clin Psychopharmacol.  2002; 10 (3): 295-301
• Young adults' opinions of Philip Morris and its television advertising. Henriksen L,  Fortmann SP.  Tob Control.  2002; 11 (3): 236-40
• Generalizability of findings from a chewing tobacco cessation clinical trial. Howard-Pitney B,  Fortmann SP, Killen JD.  Nicotine Tob Res.  2001; 3 (4): 347-52
• An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Wrone EM,  Zehnder JL, Hornberger JM, McCann LM, Coplon NS, Fortmann SP.  Kidney Int.  2001; 60 (3): 1106-13
• Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Molarius A,  Parsons RW, Dobson AJ, Evans A, Fortmann SP, Jamrozik K, Kuulasmaa K, Moltchanov V, Sans S, Tuomilehto J, Puska P.  Am J Public Health.  2001; 91 (2): 206-12
• Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project. Gardner CD,  Tribble DL, Young DR, Ahn D, Fortmann SP.  Prev Med.  2000; 31 (4): 346-56
• Nicotine patch and paroxetine for smoking cessation. Killen JD,  Fortmann SP, Schatzberg AF, Hayward C, Sussman L, Rothman M, Strausberg L, Varady A.  J Consult Clin Psychol.  2000; 68 (5): 883-9
• Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Cooper R,  Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T.  Circulation.  2000; 102 (25): 3137-47
• Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). Gardner CD,  Winkleby MA, Fortmann SP.  Am J Cardiol.  2000; 86 (3): 299-304
• Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project. Gardner CD,  Tribble DL, Young DR, Ahn D, Fortmann SP.  Prev Med.  2000; 31 (4): 335-45
• Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: the Stanford Five-City Project. Fortmann SP,  Varady AN.  Am J Epidemiol.  2000; 152 (4): 316-23
• The relationship between tobacco access and use among adolescents: a four community study. Altman DG,  Wheelis AY, McFarlane M, Lee H, Fortmann SP.  Soc Sci Med.  1999; 48 (6): 759-75
• Are higher doses of nicotine replacement more effective for smoking cessation? Hughes JR,  Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, Broughton JO, Fortmann SP, Leischow SJ, McKenna JP, Rennard SI, Wadland WC, Heatley SA.  Nicotine Tob Res.  1999; 1 (2): 169-74
• Do heavy smokers benefit from higher dose nicotine patch therapy? Killen JD,  Fortmann SP, Davis L, Strausberg L, Varady A.  Exp Clin Psychopharmacol.  1999; 7 (3): 226-33
• Primordial prevention of cardiovascular disease risk factors: panel summary. Stamler J,  Fortmann SP, Levy RI, Prineas RJ, Tell G.  Prev Med.  1999; 29 (6 Pt 2): S130-5
• The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Daughton DM,  Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, Ullrich F, Patil KD, Rennard SI.  Prev Med.  1999; 28 (2): 113-8
• Quitting chew: results from a randomized trial using nicotine patches. Howard-Pitney B,  Killen JD, Fortmann SP.  Exp Clin Psychopharmacol.  1999; 7 (4): 362-71
• Determinants of cholesterol screening and treatment patterns. Insights for decision-makers. Davis SK,  Ahn DK, Fortmann SP, Farquhar JW.  Am J Prev Med.  1998; 15 (3): 178-86
• Changes in cigarette smoking among adults in 35 populations in the mid-1980s. WHO MONICA Project. Dobson AJ,  Kuulasmaa K, Moltchanov V, Evans A, Fortmann SP, Jamrozik K, Sans S, Tuomilehto J.  Tob Control.  1998; 7 (1): 14-21
• The effect of perceived control over eating on the life satisfaction of women and men: results from a community sample. Greeno CG,  Jackson C, Williams EL, Fortmann SP.  Int J Eat Disord.  1998; 24 (4): 415-9
• The interplay of socioeconomic status and ethnicity on Hispanic and white men's cardiovascular disease risk and health communication patterns. Ribisl KM,  Winkleby MA, Fortmann SP, Flora JA.  Health Educ Res.  1998; 13 (3): 407-17
• Predicting achievement of a low-fat diet: a nutrition intervention for adults with low literacy skills. Winkleby MA,  Howard-Pitney B, Albright CA, Bruce B, Kraemer HC, Fortmann SP.  Prev Med.  1997 Nov-Dec; 26 (6): 874-82
• A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Wild SH,  Fortmann SP, Marcovina SM.  Arterioscler Thromb Vasc Biol.  1997; 17 (2): 239-45
• Nicotine patch and self-help video for cigarette smoking cessation. Killen JD,  Fortmann SP, Davis L, Varady A.  J Consult Clin Psychol.  1997; 65 (4): 663-72
• Craving is associated with smoking relapse: findings from three prospective studies. Killen JD,  Fortmann SP.  Exp Clin Psychopharmacol.  1997; 5 (2): 137-42
• The Stanford Nutrition Action Program: a dietary fat intervention for low-literacy adults. Howard-Pitney B,  Winkleby MA, Albright CL, Bruce B, Fortmann SP.  Am J Public Health.  1997; 87 (12): 1971-6
• Lipoprotein(a), a clinically elusive lipoprotein particle. Fortmann SP,  Marcovina SM.  Circulation.  1997; 95 (2): 295-6
• Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Gardner CD,  Fortmann SP, Krauss RM.  JAMA.  1996; 276 (11): 875-81
• Sociodemographic influences on Hispanic-white differences in blood pressure. Winkleby MA,  Kraemer H, Lin J, Jatulis D, Fortmann SP.  Public Health Rep.  1996; 111 Suppl 2 30-2
• Differences in treatment of acute myocardial infarction by sex, age, and other factors (the Stanford Five-City Project). Oka RK,  Fortmann SP, Varady AN.  Am J Cardiol.  1996; 78 (8): 861-5
• Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse. Killen JD,  Fortmann SP, Kraemer HC, Varady AN, Davis L, Newman B.  J Consult Clin Psychol.  1996; 64 (5): 1060-7
• Effect of community health education on physical activity knowledge, attitudes, and behavior. The Stanford Five-City Project. Young DR,  Haskell WL, Taylor CB, Fortmann SP.  Am J Epidemiol.  1996; 144 (3): 264-74
• The long-term effects of a cardiovascular disease prevention trial: the Stanford Five-City Project. Winkleby MA,  Taylor CB, Jatulis D, Fortmann SP.  Am J Public Health.  1996; 86 (12): 1773-9
• Mortality from coronary heart disease and stroke for six ethnic groups in California, 1985 to 1990. Wild SH,  Laws A, Fortmann SP, Varady AN, Byrne CD.  Ann Epidemiol.  1995; 5 (6): 432-9
• Weight variability effects: a prospective analysis from the Stanford Five-City Project. Taylor CB,  Jatulis DE, Fortmann SP, Kraemer HC.  Am J Epidemiol.  1995; 141 (5): 461-5
• Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. Fortmann SP,  Killen JD.  J Consult Clin Psychol.  1995; 63 (3): 460-8
• Hispanic versus white smoking patterns by sex and level of education. Winkleby MA,  Schooler C, Kraemer HC, Lin J, Fortmann SP.  Am J Epidemiol.  1995; 142 (4): 410-8
• Community intervention trials: reflections on the Stanford Five-City Project Experience. Fortmann SP,  Flora JA, Winkleby MA, Schooler C, Taylor CB, Farquhar JW.  Am J Epidemiol.  1995; 142 (6): 576-86
• Hispanic/white differences in dietary fat intake among low educated adults and children. Winkleby MA,  Albright CL, Howard-Pitney B, Lin J, Fortmann SP.  Prev Med.  1994; 23 (4): 465-73
• Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies. Fortmann SP,  Killen JD.  Am J Epidemiol.  1994; 140 (1): 39-51
• The capacity-building approach to intervention maintenance implemented by the Stanford Five-City Project. Jackson C,  Fortmann SP, Flora JA, Melton RJ, Snider JP, Littlefield D.  Health Educ Res.  1994; 9 (3): 385-96
• Role of nicotine dependence in smoking relapse: results from a prospective study using population-based recruitment methodology. Killen JD,  Fortmann SP.  Int J Behav Med.  1994; 1 (4): 320-34
• Improvements in cholesterol-related knowledge and behavior and plasma cholesterol levels in youths during the 1980s. Frank E,  Winkleby M, Fortmann SP, Rockhill B, Farquhar JW.  Am J Prev Med.  1993 May-Jun; 9 (3): 168-74
• Health-related risk factors in a sample of Hispanics and whites matched on sociodemographic characteristics. The Stanford Five-City Project. Winkleby MA,  Fortmann SP, Rockhill B.  Am J Epidemiol.  1993; 137 (12): 1365-75
• Changes in adult cigarette smoking prevalence after 5 years of community health education: the Stanford Five-City Project. Fortmann SP,  Taylor CB, Flora JA, Jatulis DE.  Am J Epidemiol.  1993; 137 (1): 82-96
• The favorite cigarette of the day. Jarvik M,  Killen JD, Varady A, Fortmann SP.  J Behav Med.  1993; 16 (4): 413-22
• Effect of community health education on plasma cholesterol levels and diet: the Stanford Five-City Project. Fortmann SP,  Taylor CB, Flora JA, Winkleby MA.  Am J Epidemiol.  1993; 137 (10): 1039-55
• Changes in coronary heart disease risk factors in the 1980s: evidence of a male-female crossover effect with age. Williams EL,  Winkleby MA, Fortmann SP.  Am J Epidemiol.  1993; 137 (10): 1056-67
• Cardiovascular disease risk factors: improvements in knowledge and behavior in the 1980s. Frank E,  Winkleby M, Fortmann SP, Farquhar JW.  Am J Public Health.  1993; 83 (4): 590-3
• Associations between changes in physical activity and risk factors for coronary heart disease in a community-based sample of men and women: the Stanford Five-City Project. Young DR,  Haskell WL, Jatulis DE, Fortmann SP.  Am J Epidemiol.  1993; 138 (4): 205-16
• Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. Tribble DL,  Giuliano LJ, Fortmann SP.  Am J Clin Nutr.  1993; 58 (6): 886-90
• Improved cholesterol-related knowledge and behavior and plasma cholesterol levels in adults during the 1980s. Frank E,  Winkleby MA, Fortmann SP, Rockhill B, Farquhar JW.  JAMA.  1992 Sep 23-30; 268 (12): 1566-72
• Effect of minor illness on serum cholesterol level. Hyman DJ,  Barrett DC, Fortmann SP.  Am J Prev Med.  1992 Mar-Apr; 8 (2): 100-3
• Cholesterol treatment practices of primary care physicians. Hyman DJ,  Maibach EW, Flora JA, Fortmann SP.  Public Health Rep.  1992 Jul-Aug; 107 (4): 441-8
• Trends in cardiovascular disease risk factors by educational level: the Stanford Five-City Project. Winkleby MA,  Fortmann SP, Rockhill B.  Prev Med.  1992; 21 (5): 592-601
• Impact of a clinical preventive medicine curriculum for primary care faculty: results of a dissemination model. Albright CL,  Farquhar JW, Fortmann SP, Sachs DP, Owens DK, Gottlieb L, Stratos GA, Bergen MR, Skeff KM.  Prev Med.  1992; 21 (4): 419-35
• Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Winkleby MA,  Jatulis DE, Frank E, Fortmann SP.  Am J Public Health.  1992; 82 (6): 816-20
• The medical origins of homelessness. Winkleby MA,  Rockhill B, Jatulis D, Fortmann SP.  Am J Public Health.  1992; 82 (10): 1394-8
• The Behavioral Risk Factor Survey and the Stanford Five-City Project Survey: a comparison of cardiovascular risk behavior estimates. Jackson C,  Jatulis DE, Fortmann SP.  Am J Public Health.  1992; 82 (3): 412-6
• Policy alternatives for reducing tobacco sales to minors: results from a national survey of retail chain and franchise stores. Altman DG,  Linzer J, Kropp R, Descheemaeker N, Feighery E, Fortmann SP.  J Public Health Policy.  1992; 13 (3): 318-31
• Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. Killen JD,  Fortmann SP, Kraemer HC, Varady A, Newman B.  J Consult Clin Psychol.  1992; 60 (5): 797-801
• Use of educational resources for cardiovascular risk reduction in the Stanford Five-City Project. Jackson C,  Winkleby MA, Flora JA, Fortmann SP.  Am J Prev Med.  1991 Mar-Apr; 7 (2): 82-8
• Some cautions in labeling effects. Rudd P,  Fortmann SP.  Arch Intern Med.  1991; 151 (11): 2313
• Predictors of physician's smoking cessation advice. Frank E,  Winkleby MA, Altman DG, Rockhill B, Fortmann SP.  JAMA.  1991; 266 (22): 3139-44
• Effect of long-term community health education on body mass index. The Stanford Five-City Project. Taylor CB,  Fortmann SP, Flora J, Kayman S, Barrett DC, Jatulis D, Farquhar JW.  Am J Epidemiol.  1991; 134 (3): 235-49
• Prospective study of factors influencing the development of craving associated with smoking cessation. Killen JD,  Fortmann SP, Newman B, Varady A.  Psychopharmacology (Berl).  1991; 105 (2): 191-6
• Weight change among participants in a large sample minimal contact smoking relapse prevention trial. Killen JD,  Fortmann SP, Newman B.  Addict Behav.  1990; 15 (4): 323-32
• Social class disparities in risk factors for disease: eight-year prevalence patterns by level of education. Winkleby MA,  Fortmann SP, Barrett DC.  Prev Med.  1990; 19 (1): 1-12
• Restaurant menu labeling: impact of nutrition information on entree sales and patron attitudes. Albright CL,  Flora JA, Fortmann SP.  Health Educ Q.  1990; 17 (2): 157-67
• Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. Killen JD,  Fortmann SP, Newman B, Varady A.  J Consult Clin Psychol.  1990; 58 (1): 85-92
• Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. Farquhar JW,  Fortmann SP, Flora JA, Taylor CB, Haskell WL, Williams PT, Maccoby N, Wood PD.  JAMA.  1990; 264 (3): 359-65
• Effect of long-term community health education on blood pressure and hypertension control. The Stanford Five-City Project. Fortmann SP,  Winkleby MA, Flora JA, Haskell WL, Taylor CB.  Am J Epidemiol.  1990; 132 (4): 629-46
• Some pitfalls in disease screening. Rudd P,  Fortmann SP.  Arch Intern Med.  1990; 150 (5): 1121, 1124-5
• Effects of weight loss on clinic and ambulatory blood pressure in normotensive men. Fortmann SP,  Haskell WL, Wood PD.  Am J Cardiol.  1988; 62 (1): 89-93
• Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. Wood PD,  Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, Superko HR, Fortmann SP, Albers JJ, Vranizan KM.  N Engl J Med.  1988; 319 (18): 1173-9
• Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. Killen JD,  Fortmann SP, Telch MJ, Newman B.  JAMA.  1988; 260 (11): 1581-5
• Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. Fortmann SP,  Killen JD, Telch MJ, Newman B.  JAMA.  1988; 260 (11): 1575-80
• The cost-effectiveness of three smoking cessation programs. Altman DG,  Flora JA, Fortmann SP, Farquhar JW.  Am J Public Health.  1987; 77 (2): 162-5
• Nicotine yield and measures of cigarette smoke exposure in a large population: are lower-yield cigarettes safer? Maron DJ,  Fortmann SP.  Am J Public Health.  1987; 77 (5): 546-9
• Associations of dietary fat, regional adiposity, and blood pressure in men. Williams PT,  Fortmann SP, Terry RB, Garay SC, Vranizan KM, Ellsworth N, Wood PD.  JAMA.  1987; 257 (23): 3251-6
• Smokers' challenge: immediate and long-term findings of a community smoking cessation contest. King AC,  Flora JA, Fortmann SP, Taylor CB.  Am J Public Health.  1987; 77 (10): 1340-1
• Consequences of worksite hypertension screening. Changes in absenteeism. Rudd P,  Price MG, Graham LE, Beilstein BA, Tarbell SJ, Bacchetti P, Fortmann SP.  Hypertension.  1987; 10 (4): 425-36
• Efficacy of self-help behavior modification materials in smoking cessation. Sallis JF,  Hill RD, Killen JD, Telch MJ, Flora JA, Girard J, Taylor CB, Fortmann SP.  Am J Prev Med.  1986 Nov-Dec; 2 (6): 342-4
• Moderate-intensity physical activity and cardiovascular risk factors: the Stanford Five-City Project. Sallis JF,  Haskell WL, Fortmann SP, Wood PD, Vranizan KM.  Prev Med.  1986; 15 (6): 561-8
• Changes in plasma high density lipoprotein cholesterol after changes in cigarette use. Fortmann SP,  Haskell WL, Williams PT.  Am J Epidemiol.  1986; 124 (4): 706-10
• Predictors of adoption and maintenance of physical activity in a community sample. Sallis JF,  Haskell WL, Fortmann SP, Vranizan KM, Taylor CB, Solomon DS.  Prev Med.  1986; 15 (4): 331-41
• Consequences of worksite hypertension screening. Differential changes in psychosocial function. Rudd P,  Price MG, Graham LE, Beilstein BA, Tarbell SJ, Bacchetti P, Fortmann SP.  Am J Med.  1986; 80 (5): 853-60
• Community surveillance of cardiovascular diseases in the Stanford Five-City Project. Methods and initial experience. Fortmann SP,  Haskell WL, Williams PT, Varady AN, Hulley SB, Farquhar JW.  Am J Epidemiol.  1986; 123 (4): 656-69
• Health behavior change at the worksite: cardiovascular risk reduction. Sallis JF,  Hill RD, Fortmann SP, Flora JA.  Prog Behav Modif.  1986; 20 161-97
• Vigorous physical activity and cardiovascular risk factors in young adults. Sallis JF,  Haskell WL, Wood PD, Fortmann SP, Vranizan KM.  J Chronic Dis.  1986; 39 (2): 115-20
• Attitudes and practices of physicians regarding hypertension and smoking: The Stanford Five City Project. Fortmann SP,  Sallis JF, Magnus PM, Farquhar JW.  Prev Med.  1985; 14 (1): 70-80
• The Stanford Five-City Project: design and methods. Farquhar JW,  Fortmann SP, Maccoby N, Haskell WL, Williams PT, Flora JA, Taylor CB, Brown BW, Solomon DS, Hulley SB.  Am J Epidemiol.  1985; 122 (2): 323-34
• Mediated smoking cessation programs in the Stanford Five-City Project. Sallis JF,  Flora JA, Fortmann SP, Taylor CB, Maccoby N.  Addict Behav.  1985; 10 (4): 441-3
• Combining behavioral treatments to reduce blood pressure. A controlled outcome study. Jacob RG,  Fortmann SP, Kraemer HC, Farquhar JW, Agras WS.  Behav Modif.  1985; 9 (1): 32-53
• Physical activity assessment methodology in the Five-City Project. Sallis JF,  Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, Paffenbarger RS.  Am J Epidemiol.  1985; 121 (1): 91-106
• Increasing returns of physician surveys. Sallis JF,  Fortmann SP, Solomon DS, Farquhar JW.  Am J Public Health.  1984; 74 (9): 1043
• International diagnostic criteria for acute myocardial infarction and acute stroke. Gillum RF,  Fortmann SP, Prineas RJ, Kottke TE.  Am Heart J.  1984; 108 (1): 150-8
• Indirect measures of cigarette use: expired-air carbon monoxide versus plasma thiocyanate. Fortmann SP,  Rogers T, Vranizan K, Haskell WL, Solomon DS, Farquhar JW.  Prev Med.  1984; 13 (1): 127-35
• The association of blood pressure and dietary alcohol: differences by age, sex, and estrogen use. Fortmann SP,  Haskell WL, Vranizan K, Brown BW, Farquhar JW.  Am J Epidemiol.  1983; 118 (4): 497-507
• Essential hypertension. Taylor CB,  Fortmann SP.  Psychosomatics.  1983; 24 (5): 433-48
• Does dietary health education reach only the privileged? The Stanford Three Community Study. Fortmann SP,  Williams PT, Hulley SB, Maccoby N, Farquhar JW.  Circulation.  1982; 66 (1): 77-82
• Effect of health education on dietary behavior: the Stanford Three Community Study. Fortmann SP,  Williams PT, Hulley SB, Haskell WL, Farquhar JW.  Am J Clin Nutr.  1981; 34 (10): 2030-8
• A comparison of the Sphygmetrics SR-2 Automatic Blood Pressure Recorder to the mercury sphygmomanometer in population studies. Fortmann SP,  Marcuson R, Bitter PH, Haskell WL.  Am J Epidemiol.  1981; 114 (6): 836-44
• A comparison of statistical methods for evaluating risk factor changes in community-based studies: an example from the Stanford Three-Community Study. Williams PT,  Fortmann SP, Farquhar JW, Varady A, Mellen S.  J Chronic Dis.  1981; 34 (11): 565-71
• Abortion and medicine. Fortmann SP,  Pharos Alpha Omega Alpha Honor Med Soc.  1975; 38 (1): 25-9